Logo image of KIN.BR

KINEPOLIS (KIN.BR) Stock Fundamental Analysis

Europe - EBR:KIN - BE0974274061 - Common Stock

32.5 EUR
+0.15 (+0.46%)
Last: 9/16/2025, 5:35:30 PM
Fundamental Rating

4

Overall KIN gets a fundamental rating of 4 out of 10. We evaluated KIN against 46 industry peers in the Entertainment industry. While KIN is still in line with the averages on profitability rating, there are concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on KIN.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year KIN was profitable.
KIN had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: KIN reported negative net income in multiple years.
Of the past 5 years KIN 4 years had a positive operating cash flow.
KIN.BR Yearly Net Income VS EBIT VS OCF VS FCFKIN.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

KIN has a Return On Assets of 4.54%. This is in the better half of the industry: KIN outperforms 67.39% of its industry peers.
The Return On Equity of KIN (23.61%) is better than 82.61% of its industry peers.
KIN's Return On Invested Capital of 8.28% is fine compared to the rest of the industry. KIN outperforms 71.74% of its industry peers.
KIN had an Average Return On Invested Capital over the past 3 years of 6.76%. This is below the industry average of 10.51%.
The 3 year average ROIC (6.76%) for KIN is below the current ROIC(8.28%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.54%
ROE 23.61%
ROIC 8.28%
ROA(3y)3.57%
ROA(5y)0.53%
ROE(3y)21.42%
ROE(5y)-2.24%
ROIC(3y)6.76%
ROIC(5y)N/A
KIN.BR Yearly ROA, ROE, ROICKIN.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

KIN has a better Profit Margin (7.98%) than 69.57% of its industry peers.
KIN's Profit Margin has declined in the last couple of years.
KIN has a Operating Margin of 15.19%. This is amongst the best in the industry. KIN outperforms 84.78% of its industry peers.
KIN's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 24.54%, KIN is not doing good in the industry: 89.13% of the companies in the same industry are doing better.
KIN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 15.19%
PM (TTM) 7.98%
GM 24.54%
OM growth 3YN/A
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5Y-6.62%
GM growth 3Y115.73%
GM growth 5Y-3.42%
KIN.BR Yearly Profit, Operating, Gross MarginsKIN.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

2

2. Health

2.1 Basic Checks

KIN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, KIN has about the same amount of shares outstanding.
The number of shares outstanding for KIN has been increased compared to 5 years ago.
The debt/assets ratio for KIN has been reduced compared to a year ago.
KIN.BR Yearly Shares OutstandingKIN.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
KIN.BR Yearly Total Debt VS Total AssetsKIN.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

KIN has an Altman-Z score of 1.59. This is a bad value and indicates that KIN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of KIN (1.59) is comparable to the rest of the industry.
The Debt to FCF ratio of KIN is 5.38, which is a neutral value as it means it would take KIN, 5.38 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 5.38, KIN perfoms like the industry average, outperforming 54.35% of the companies in the same industry.
KIN has a Debt/Equity ratio of 2.87. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.87, KIN is not doing good in the industry: 69.57% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF 5.38
Altman-Z 1.59
ROIC/WACC1.56
WACC5.31%
KIN.BR Yearly LT Debt VS Equity VS FCFKIN.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

KIN has a Current Ratio of 0.47. This is a bad value and indicates that KIN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.47, KIN is not doing good in the industry: 82.61% of the companies in the same industry are doing better.
A Quick Ratio of 0.44 indicates that KIN may have some problems paying its short term obligations.
The Quick ratio of KIN (0.44) is worse than 84.78% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.44
KIN.BR Yearly Current Assets VS Current LiabilitesKIN.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

5

3. Growth

3.1 Past

KIN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.32%, which is quite impressive.
Measured over the past years, KIN shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.80% on average per year.
KIN shows a small growth in Revenue. In the last year, the Revenue has grown by 5.38%.
KIN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.95% yearly.
EPS 1Y (TTM)34.32%
EPS 3YN/A
EPS 5Y-5.8%
EPS Q2Q%5581.82%
Revenue 1Y (TTM)5.38%
Revenue growth 3Y29.47%
Revenue growth 5Y0.95%
Sales Q2Q%6.22%

3.2 Future

The Earnings Per Share is expected to grow by 15.11% on average over the next years. This is quite good.
KIN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.98% yearly.
EPS Next Y37.47%
EPS Next 2Y27.44%
EPS Next 3Y21.34%
EPS Next 5Y15.11%
Revenue Next Year4.68%
Revenue Next 2Y5.5%
Revenue Next 3Y5.08%
Revenue Next 5Y4.98%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
KIN.BR Yearly Revenue VS EstimatesKIN.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M
KIN.BR Yearly EPS VS EstimatesKIN.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2

7

4. Valuation

4.1 Price/Earnings Ratio

KIN is valuated rather expensively with a Price/Earnings ratio of 19.01.
Based on the Price/Earnings ratio, KIN is valued cheaply inside the industry as 86.96% of the companies are valued more expensively.
KIN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.27.
With a Price/Forward Earnings ratio of 11.94, the valuation of KIN can be described as very reasonable.
KIN's Price/Forward Earnings ratio is rather cheap when compared to the industry. KIN is cheaper than 84.78% of the companies in the same industry.
KIN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.77.
Industry RankSector Rank
PE 19.01
Fwd PE 11.94
KIN.BR Price Earnings VS Forward Price EarningsKIN.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

65.22% of the companies in the same industry are more expensive than KIN, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, KIN is valued cheaply inside the industry as 86.96% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.81
EV/EBITDA 8.88
KIN.BR Per share dataKIN.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

KIN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
KIN's earnings are expected to grow with 21.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.51
PEG (5Y)N/A
EPS Next 2Y27.44%
EPS Next 3Y21.34%

3

5. Dividend

5.1 Amount

KIN has a Yearly Dividend Yield of 1.16%.
Compared to an average industry Dividend Yield of 1.96, KIN pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, KIN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.16%

5.2 History

The dividend of KIN decreases each year by -3.32%.
Dividend Growth(5Y)-3.32%
Div Incr Years1
Div Non Decr Years2
KIN.BR Yearly Dividends per shareKIN.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

KIN pays out 31.09% of its income as dividend. This is a sustainable payout ratio.
DP31.09%
EPS Next 2Y27.44%
EPS Next 3Y21.34%
KIN.BR Yearly Income VS Free CF VS DividendKIN.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
KIN.BR Dividend Payout.KIN.BR Dividend Payout, showing the Payout Ratio.KIN.BR Dividend Payout.PayoutRetained Earnings

KINEPOLIS

EBR:KIN (9/16/2025, 5:35:30 PM)

32.5

+0.15 (+0.46%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-21 2025-08-21
Earnings (Next)N/A N/A
Inst Owners15.64%
Inst Owner ChangeN/A
Ins Owners1.8%
Ins Owner ChangeN/A
Market Cap889.52M
Analysts86
Price Target49.47 (52.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.16%
Yearly Dividend0.54
Dividend Growth(5Y)-3.32%
DP31.09%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.34%
PT rev (3m)-2.02%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-7.61%
EPS NY rev (3m)-7.61%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.3%
Revenue NY rev (3m)-2.16%
Valuation
Industry RankSector Rank
PE 19.01
Fwd PE 11.94
P/S 1.5
P/FCF 6.81
P/OCF 5.13
P/B 4.44
P/tB 39.69
EV/EBITDA 8.88
EPS(TTM)1.71
EY5.26%
EPS(NY)2.72
Fwd EY8.38%
FCF(TTM)4.77
FCFY14.68%
OCF(TTM)6.34
OCFY19.5%
SpS21.68
BVpS7.32
TBVpS0.82
PEG (NY)0.51
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.54%
ROE 23.61%
ROCE 11.27%
ROIC 8.28%
ROICexc 8.93%
ROICexgc 11.76%
OM 15.19%
PM (TTM) 7.98%
GM 24.54%
FCFM 22.02%
ROA(3y)3.57%
ROA(5y)0.53%
ROE(3y)21.42%
ROE(5y)-2.24%
ROIC(3y)6.76%
ROIC(5y)N/A
ROICexc(3y)7.02%
ROICexc(5y)N/A
ROICexgc(3y)8.91%
ROICexgc(5y)N/A
ROCE(3y)9.19%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-1%
ROICexc growth 3YN/A
ROICexc growth 5Y-1.69%
OM growth 3YN/A
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5Y-6.62%
GM growth 3Y115.73%
GM growth 5Y-3.42%
F-Score8
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF 5.38
Debt/EBITDA 3.35
Cap/Depr 52.23%
Cap/Sales 7.23%
Interest Coverage 4.1
Cash Conversion 100.75%
Profit Quality 276.05%
Current Ratio 0.47
Quick Ratio 0.44
Altman-Z 1.59
F-Score8
WACC5.31%
ROIC/WACC1.56
Cap/Depr(3y)43.12%
Cap/Depr(5y)41.32%
Cap/Sales(3y)6.29%
Cap/Sales(5y)10.19%
Profit Quality(3y)301.12%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.32%
EPS 3YN/A
EPS 5Y-5.8%
EPS Q2Q%5581.82%
EPS Next Y37.47%
EPS Next 2Y27.44%
EPS Next 3Y21.34%
EPS Next 5Y15.11%
Revenue 1Y (TTM)5.38%
Revenue growth 3Y29.47%
Revenue growth 5Y0.95%
Sales Q2Q%6.22%
Revenue Next Year4.68%
Revenue Next 2Y5.5%
Revenue Next 3Y5.08%
Revenue Next 5Y4.98%
EBIT growth 1Y16.5%
EBIT growth 3YN/A
EBIT growth 5Y-3.89%
EBIT Next Year112.63%
EBIT Next 3Y32.23%
EBIT Next 5Y22.36%
FCF growth 1Y30.27%
FCF growth 3Y19%
FCF growth 5Y6.53%
OCF growth 1Y26.43%
OCF growth 3Y22.57%
OCF growth 5Y1.63%